Ocular surface disease
2 papers2 findings
Interventions
1GLP-1 receptor agonists
downin humans1
1 study
GLP-1 receptor agonists
downin humans1
GLP-1 receptor agonists decrease ocular surface disease in humans.
“Ocular surface improvements have been observed in some studies.”
Reviewocular surface
Journal of clinical medicine12 Dec 2025
Associations
1Corneal aging
upin reviews1
1 study
Corneal aging
upin reviews1
Corneal aging raises the risk of ocular surface disease.
“the cornea undergoes significant structural and functional changes during aging, making individuals more prone to various ocular surface diseases.”
Reviewcornea
The aging cornea: From mechanisms to clinical applications
Ageing research reviews16 Mar 2026
Trial sponsors
1 trialPhase 460 people
Latest
3 in 12 monthsFrontiers in Cell and Developmental Biology
Age-related lncRNA alterations of SDHAP2_miR-17-5p/miR-20b-5p_RAB11FIP1 ceRNA network in donor-derived human limbal epithelial cells
Study in peopleMechanisms
Journal of Clinical Medicine
Functional and Aesthetic Periorbital, Ocular Adnexal and Ocular Surface Changes Linked to GLP-1 Receptor Agonists
Systematic reviewGLP-1 receptor agonists
Experimental Eye Research
Multi-omics analysis reveals lipid metabolism profiles and regulatory networks in meibomian glands aging
Experiments in miceLipid and ceramide metabolism